Updates from The Motley Fool

Latest updates on United Therapeutics Corp from Fool.com.

Stock Performance

UTHR vs. S&P 500 | 2 Year Performance
UTHR 1-Day Stock Chart
UTHR 5-Day Stock Chart
UTHR 1-Month Stock Chart
UTHR 3-Month Stock Chart
UTHR 6-Month Stock Chart
UTHR 1-Year Stock Chart
UTHR 2-Year Stock Chart
UTHR 5-Year Stock Chart
View Interactive UTHR Charts
Sponsored by

Key Data Points

Primary metrics and data points about United Therapeutics Corp.
Current Price: $117.78
Prev Close: $117.15
Open: $116.98
Bid: $115.84
Ask: $121.45
Day's Range: $115.64 - $117.89
52wk Range: $102.50 - $190.13
Volume: 406,275
Avg Vol 679,392
Market Cap: $5.37B
P/E (ttm): 9.21
EPS (ttm): $12.72
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about United Therapeutics Corp.
CAPS Rating 5 out of 5
260 Outperform
16 Underperform
CAPS All Stars
70 Outperform
4 Underperform

How do you think United Therapeutics Corp will perform against the market?

You pick for United Therapeutics Corp is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Martine A. Rothblatt, CEO

100% Approve

Based on 26 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for United Therapeutics Corp.

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers